Stockreport

Nektar Therapeutics (NKTR): A Bull Case Theory [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Nektar Therapeutics's share was trading at $35.23 as of January 29th. Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies [Read more]